Neurogene Inc.

NASDAQ:NGNE

Biotechnology

Healthcare
$23.10 +2.47%

+$0.76 today

Market cap
$365.03M
Beta
2.04
P/E (TTM)
-7.1
EPS (TTM)
-$4.42
52W Low $14.65High $37.27

Volume 0.28M

Average 0.16M

Price history

Neurogene Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+8.15%

Period high

$42.84

Period low

$16.37

Latest

$23.10

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 9, 2026Nov 9, 2026
8-KNov 9, 2026Nov 9, 2026
SC 13GOct 7, 2026Oct 7, 2026
SC 13GOct 6, 2026Oct 6, 2026
4Oct 2, 2026Oct 2, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13GAug 14, 2026Aug 14, 2026
10-QAug 11, 2026Aug 11, 2026
8-KAug 11, 2026Aug 11, 2026
4Jul 7, 2026Jul 7, 2026
4Jul 2, 2026Jul 2, 2026
8-KJul 2, 2026Jul 1, 2026
424B5Jul 2, 2026Jul 1, 2026
424B5Jun 30, 2026Jun 30, 2026

Competitors

Who does Neurogene Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about NGNE's filings, answered from its disclosures.

What is the latest NGNE filing?

The latest filing shown is 8-K dated Nov 9, 2026.

How many recent filings does NGNE have?

Intrinsic Alpha currently shows 20 recent filings for NGNE.